- York House Church Lane, Chalfont St Peter,
Gerrards Cross, Buckinghamshire, SL9 9RE - 666-888-0000
- info@tersanpharm.com
- info@tersanpharm.com
- York House Church Lane, Chalfont St Peter,
Gerrards Cross, Buckinghamshire, SL9 9RE - Contact Us
Nov2019
Comorbidities play an important role in hospitalized influenza mortality risk, Real World Evidence (RWE) study performed by Tersan and Sanofi Pasteur shows
Big Data analysis of over 125 Million patient hospitalization records using Tersan’s data analytics and AI platform identifies significant factors increasing Case Fatality Rates Paris and Boston, November 7th 2019. Tersan Pharmaceuticals Ltd, a leading digital health Company announced the publication of an influenza Real World analysis in collaboration with Sanofi-Pasteur. Influenza-related mortality for hospitalized patients […]
Jul2019
Alzheimer’s Disease/Dementia Early Detection and Precision Medicine Using KEM® Artificial Intelligence (AI): latest research results presented by ARIANA at the AAIC 2019.
Gut Microbiota biomarkers associated with improved drug response, as well as genomic biomarkers for early detection of patients at risk were identified using Tersan’s KEM® Explainable AI (XAI) in 3 separate oral presentations. response, as well as genomic biomarkers for early detection of patients at risk were identified using Tersan’s KEM® Explainable AI (XAI) in […]
Jun2019
Appointment of Federico Goodsaid, PhD to the position of Senior Vice President for Regulatory Affairs
Tersan® Pharma announces the appointment of Federico Goodsaid, PhD to the position of Senior Vice President for Regulatory Affairs Paris, France and Cambridge,MA – June 18, 2019 – Tersan Pharmaceuticals Ltd (Paris, France and Cambridge, MA), a leading digital health company focused on developing advanced Artificial Intelligence technologies for patient stratification in clinical trials, today announced the […]
May2017
API 2017 (Panama | May 16-20)
Two posters highlighting the use of Tersan’s Real World Evidence (RWE) platform for large scale data mining of healthcare records are to be presented at API 2017 (Asociacion Panamericana de Infectologia) – XVIII Congresso Panamericano de Infectologia, Panama, 16-20 May 2017. The studies focus on retrospective analyses of risk factors for dengue mortality in hospitalized […]
Nov2016
Tersan to showcase Real World Evidence platform at ASTMH 2016 (Atlanta, USA | Nov 13-17)
Dr David Morley, VP Computational Technology, will be co-presenting a poster at the 65th Annual Meeting of the American Society of Tropical Medicine and Hygiene (ASTMH 2016) in Atlanta, USA. Poster 212 “Management of dengue hospitalizations in Brazil during and outside epidemic periods: Insights from Data Mining” is a joint presentation with Sanofi Pasteur and […]